Latest News & Events
The next working group meetings of the Action will be held on 7th of March 2020 in Regensburg, Germany.
I am Joanna Wielińska, a PhD student in Professor Katarzyna Bogunia-Kubik’s Laboratory of Clinical Immunogenetics and Pharmacogenetics at the Hirszfeld Institute of Immunology and Experimental Therapy in Wroclaw, Poland.
My name is Piotr Łacina and I am a PhD student supervised by Professor Katarzyna Bogunia-Kubik at Laboratory of Clinical Immunogenetics and Pharmacogenetics of the Hirszfeld Institute of Immunology and Experimental Therapy in Wroclaw, Poland.
The workshop in Regensburg, Germany targets the current knowledge on the role of the microbiome in allogeneic HSCT and the consequences for nutrition.
Save the Date! The next working group meetings of the Action will be held on 17th-18th October 2019 in Budapast, Hungary.
The second Working Group meeting of the Action was held at the University of Pisa, Italy from 6-7th February 2019.
The first working group meeting was held from 7-8th November 2018, at the Rudjer Boskovic Institute in Zagreb, Croatia.
How molecular biology and pharmacogenetics can help to understand the immune system’s behavior during the treatment of cGVHD with immunotherapy: the role of PD-L1, Torquetenovirus and of the assessment of tyrosine kinase inhibitors plasma levels.
I am Francesca Perutelli and I am a medical doctor at the Department of Haematology of the University of Pisa, Italy. In January went to Newcastle for a 2-month STSM for Working Group 2 on ‘Molecular and Cellular Biomarkers of Chronic Graft versus Host Disease (cGvHD)’.